Society guideline links: Neutropenic fever in adults with cancer

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately:

●(See "Society guideline links: Neutropenic fever in children with cancer".)

●(See "Society guideline links: Invasive fungal infections".)

●(See "Society guideline links: Aspergillosis".)

●(See "Society guideline links: Candidiasis".)

United States

●American Society of Clinical Oncology (ASCO) and Infectious Diseases Society of America (IDSA): Clinical practice guideline on antimicrobial prophylaxis for adult patients with cancer-related immunosuppression, update (2018)

●ASCO and IDSA: Clinical practice guideline on outpatient management of fever and neutropenia in adults treated for malignancy, update (2018)

●IDSA: Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer, 2010 update (ARCHIVED; published 2011)

Europe

●European Society for Medical Oncology (ESMO): Clinical practice guidelines for the management of febrile neutropaenia (2016)

●4th European Conference on Infections in Leukemia (ECIL-4): European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance, 2011 (published 2013)